Literature DB >> 22308160

Author's Reply: Hepatitis E Virus Infection in Iranian Kidney-Transplant Patients.

Zakieh Rostamzadeh Khameneh1, Nariman Sepehrvand.   

Abstract

Entities:  

Keywords:  Hepatitis E; Iran; Kidney Transplantation

Year:  2011        PMID: 22308160      PMCID: PMC3269064          DOI: 10.5812/kowsar.1735143X.790

Source DB:  PubMed          Journal:  Hepat Mon        ISSN: 1735-143X            Impact factor:   0.660


× No keyword cloud information.
Dear Editor, On behalf of all of the coauthors, I would like to thank Dr. Kamar for his interest in our study. In the letter, Dr. Kamar summarized the most important findings on hepatitis E infection in organ transplant recipients [1], most of whom have relied on the valuable contributions by of Dr. Kamar’s group in France [2][3][4]. In our study, we noted a high seroprevalence of anti-HEV IgG. Almost 30% of transplant recipients were seropositive for anti-HEV IgG [5]. We also found unexplained increases in liver function tests in transplant recipients. However, there was no significant difference in serum alanine transferase (ALT) levels between anti-HEV-seropositive and -seronegative groups [5]. As mentioned in the letter, serological methods have certain limitations. There are doubts regarding the diagnostic value of anti-HEV IgG serological evaluation in the diagnosis of HEV infection. In a study in Taiwan, an area in which hepatitis E is not endemic, the sensitivity of anti-HEV IgG compared with reverse-transcription PCR was 86.7% [6]. Its specificity in diagnosing acute hepatitis was 92%. Lin et al. concluded that anti-HEV IgG is a good test for screening acute hepatitis E in nonendemic areas [6]. Jiang et al. evaluated the quality of diagnostic ELISA kits in detecting HEV-specific IgG using HEV diagnostic reference sera from positive and negative cases, observing that the conformity of positive results exceeded 90% in all kits [7]. In contrast, Zaki et al., in Egypt, an endemic area for hepatitis E, found the sensitivity of anti-HEV IgG to be very low (2.3%) [8]. It appears that the diagnostic value of anti-HEV IgG serological tests in endemic areas is questionable. As emphasized by Dr. Kamar, the setting of transplant recipients in Iran requires further evaluation using more specific modalities, such as polymerase chain reaction (PCR). Studying the presence of HEV RNA, its relationship with elevated liver enzymes, and acute or chronic forms of infection in these patients is recommended.
  8 in total

1.  Diagnostic value of immunoglobulin G (IgG) and IgM anti-hepatitis E virus (HEV) tests based on HEV RNA in an area where hepatitis E is not endemic.

Authors:  C C Lin; J C Wu; T T Chang; W Y Chang; M L Yu; A W Tam; S C Wang; Y H Huang; F Y Chang; S D Lee
Journal:  J Clin Microbiol       Date:  2000-11       Impact factor: 5.948

2.  Natural history of hepatitis C virus-related liver fibrosis after renal transplantation.

Authors:  Nassim Kamar; Lionel Rostaing; Janick Selves; Karine Sandres-Saune; Laurent Alric; Dominique Durand; Jacques Izopet
Journal:  Am J Transplant       Date:  2005-07       Impact factor: 8.086

3.  Hepatitis E virus and chronic hepatitis in organ-transplant recipients.

Authors:  Nassim Kamar; Janick Selves; Jean-Michel Mansuy; Leila Ouezzani; Jean-Marie Péron; Joëlle Guitard; Olivier Cointault; Laure Esposito; Florence Abravanel; Marie Danjoux; Dominique Durand; Jean-Pierre Vinel; Jacques Izopet; Lionel Rostaing
Journal:  N Engl J Med       Date:  2008-02-21       Impact factor: 91.245

4.  Value of hepatitis E virus detection by cell culture compared with nested PCR and serological studies by IgM and IgG.

Authors:  Maysaa el-Sayed Zaki; Mona F Foud; Aly F Mohamed
Journal:  FEMS Immunol Med Microbiol       Date:  2009-04-03

5.  [Evaluation of the ELISA diagnostic kits for hepatitis E virus antibody in the reference serum, the suspect patients of hepatitis E and normal persons' sera].

Authors:  Yong-zhen Jiang; Rui-guang Tian; Jian Lu; Sheng-li Bi
Journal:  Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi       Date:  2007-03

6.  Hepatitis E virus-related cirrhosis in kidney- and kidney-pancreas-transplant recipients.

Authors:  N Kamar; J-M Mansuy; O Cointault; J Selves; F Abravanel; M Danjoux; P Otal; L Esposito; D Durand; J Izopet; L Rostaing
Journal:  Am J Transplant       Date:  2008-06-28       Impact factor: 8.086

7.  Seroprevalence of hepatitis E among Iranian renal transplant recipients.

Authors:  Zakieh Rostamzadeh Khameneh; Nariman Sepehrvand; Sima Masudi
Journal:  Hepat Mon       Date:  2011-08       Impact factor: 0.660

8.  Hepatitis e virus infection in Iranian kidney-transplant patients.

Authors:  Nassim Kamar
Journal:  Hepat Mon       Date:  2011-11-30       Impact factor: 0.660

  8 in total
  1 in total

Review 1.  Hepatitis E virus in the countries of the Middle East and North Africa region: an awareness of an infectious threat to blood safety.

Authors:  Soha Yazbek; Khalil Kreidieh; Sami Ramia
Journal:  Infection       Date:  2015-06-26       Impact factor: 3.553

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.